AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 259 filers reported holding AMICUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $201,000 | -18.0% | 8,717 | -71.6% | 0.00% | 0.0% |
| Q3 2019 | $245,000 | -35.7% | 30,661 | +0.3% | 0.00% | -50.0% |
| Q2 2019 | $381,000 | -8.9% | 30,561 | -0.7% | 0.00% | 0.0% |
| Q1 2019 | $418,000 | +41.7% | 30,761 | -0.4% | 0.00% | 0.0% |
| Q4 2018 | $295,000 | -23.0% | 30,871 | -2.8% | 0.00% | 0.0% |
| Q3 2018 | $383,000 | -22.3% | 31,761 | +0.6% | 0.00% | -33.3% |
| Q2 2018 | $493,000 | +3.8% | 31,561 | -0.1% | 0.00% | 0.0% |
| Q1 2018 | $475,000 | +8.2% | 31,586 | +3.5% | 0.00% | +50.0% |
| Q4 2017 | $439,000 | – | 30,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |